EPA-Approved SARS-CoV-2 Disinfectants

9 rows where Contact_time = "1.0" and "Date_on_List_N" is on date 2021-04-13

Export this Data | Chart Risk Level by Product  Clear Chart

Add More Filters: Active_ingredient, Formulation_type,

Risk_level ✖

Use_site (array) ✖

Surface_type (array) ✖

Contact_time ✖

Date_on_List_N (date) ✖

  • 2021-04-13 · 9 ✖

 

ID ▼ EPA_reg_num Risk_level Active_ingredient Product_name Company Use_site Surface_type Contact_time Formulation_type Date_on_List_N Why_on_List_N
1076 70627-56 Safer Hydrogen peroxide Oxivir™ Tb Diversey Inc Healthcare; Institutional Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) 1.0 minutes Ready-to-use; Electrostatic spray 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1099 6836-136 Increased Risk Quaternary ammonium Lonza Formulation S-18F Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1100 6836-140 Increased Risk Quaternary ammonium Lonza Formulation S-21F Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1101 6836-152 Increased Risk Quaternary ammonium Lonza Formulation DC-103 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Ready-to-use 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1102 6836-77 Increased Risk Quaternary ammonium Lonza Formulation S-18 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1103 6836-381 Increased Risk Quaternary ammonium Lonzagard R-82G Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1104 6836-139 Increased Risk Quaternary ammonium Lonza Formulation R-82F Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1109 6836-75 Increased Risk Quaternary ammonium Lonza Formulation S-21 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim
1110 6836-78 Increased Risk Quaternary ammonium Lonza Formulation R-82 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Dilutable 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim

Export This Data

CSV options:

JSON shape: default, array, newline-delimited, object

 

➤Return to the Top

 

Our Community

External Links

Menu

Safer Disinfectants is a project of the Maryland Pesticide Education Network
© 2021. All rights reserved.